Tag: elafibranor
Primary Biliary Cholangitis Treatment: What Works in 2026
As of 2026, PBC treatment has shifted dramatically with the withdrawal of Ocaliva and the rise of seladelpar and elafibranor. Learn how UDCA remains first-line, what the new options do, and how to navigate treatment decisions.
read morerecent posts
DTC prescription drug ads in the U.S. drive higher demand for branded medications, often overshadowing equally effective generics. Research shows ads increase prescriptions but also lead to inappropriate requests and higher costs. Learn how advertising influences patient decisions and healthcare outcomes.
Published ON: 6 FebFatty foods can dramatically improve how well your body absorbs certain medications. Learn how lipid-based drug systems use dietary fat to boost bioavailability, reduce side effects, and improve treatment outcomes for chronic conditions.
Published ON: 26 FebAcupuncture for pain is backed by solid science, especially for chronic back pain, osteoarthritis, and headaches. It reduces pain without drugs, has minimal side effects, and works better than placebo in clinical trials. Learn how it works and who benefits most.
Published ON: 10 FebSubclinical hypothyroidism means elevated TSH with normal thyroid hormone levels. Should you treat it? The answer depends on your age, antibodies, symptoms, and risk factors-not just the lab number.
Published ON: 3 FebLearn why taking prescription medicine with food or on an empty stomach matters-how it affects absorption, safety, and effectiveness. Get clear guidelines for common drugs and practical tips to avoid mistakes.
Published ON: 20 Feb